Guest guest Posted April 12, 2011 Report Share Posted April 12, 2011 Vaccine-Preventable Diseases Boceprevir induced higher response rates in HCV genotype 1 Data from two studies published in The New England Journal of Medicine indicate that the addition of boceprevir to peginterferon-ribavirin treatment resulted in significantly higher rates of sustained virologic response in patients previously treated and patients with previously untreated hepatitis C virus genotype 1. Read more Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.